← FDA Drug Approvals (Drugs@FDA)

CABERGOLINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX CORP · Approved 2013-03-08

Drug application

FDA Application #

ANDA201503

Application type

Abbreviated New Drug Application (Generic)

Brand name

CABERGOLINE

Generic name

Cabergoline

Active ingredients

CABERGOLINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

APOTEX CORP

First approval

2013-03-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown